-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LmXPHYTLujwC4FyoaXB7zyd2uzZjMPT2qOK9adEQumP5WZUxea54cFIZzoO2QeHb oDv0gIzDcYP15f3nUQHrRw== 0001179110-08-001543.txt : 20080124 0001179110-08-001543.hdr.sgml : 20080124 20080124115754 ACCESSION NUMBER: 0001179110-08-001543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080122 FILED AS OF DATE: 20080124 DATE AS OF CHANGE: 20080124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sirtris Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388775 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201410189 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 104 STREET 2: 790 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-252-6920 MAIL ADDRESS: STREET 1: SUITE 104 STREET 2: 790 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Sirtris Pharmaceuticals DATE OF NAME CHANGE: 20070202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jirousek Michael CENTRAL INDEX KEY: 0001394939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33465 FILM NUMBER: 08546710 BUSINESS ADDRESS: BUSINESS PHONE: 617-252-6924 MAIL ADDRESS: STREET 1: C/O SIRTRIS PHARMACEUTICALS, INC. STREET 2: 790 MEMORIAL DR. SUITE 104 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0202 4 2008-01-22 0 0001388775 Sirtris Pharmaceuticals, Inc. SIRT 0001394939 Jirousek Michael C/O SIRTRIS PHARMACEUTICALS, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 0 1 0 0 Senior VP, Research Common Stock 2008-01-22 4 S 0 260 12.4639 D 43293 D Common Stock 2008-01-22 4 S 0 600 12.47 D 42693 D Common Stock 2008-01-22 4 S 0 399 12.48 D 42294 D Common Stock 2008-01-22 4 S 0 500 12.50 D 41794 D Common Stock 2008-01-22 4 S 0 1082 12.51 D 40712 D Common Stock 2008-01-22 4 S 0 200 12.52 D 40512 D Common Stock 2008-01-22 4 S 0 318 12.53 D 40194 D Common Stock 2008-01-22 4 S 0 200 12.54 D 39994 D Common Stock 2008-01-22 4 S 0 300 12.55 D 39694 D Common Stock 2008-01-22 4 S 0 1089 12.56 D 38605 D Common Stock 2008-01-22 4 S 0 385 12.57 D 38220 D Common Stock 2008-01-22 4 S 0 418 12.58 D 37802 D Common Stock 2008-01-22 4 S 0 242 12.59 D 37560 D Common Stock 2008-01-22 4 S 0 215 12.5907 D 37345 D Common Stock 2008-01-22 4 S 0 767 12.60 D 36578 D Common Stock 2008-01-22 4 S 0 400 12.61 D 36178 D Common Stock 2008-01-22 4 S 0 420 12.62 D 35758 D Common Stock 2008-01-22 4 S 0 400 12.63 D 35358 D Common Stock 2008-01-22 4 S 0 740 12.64 D 34618 D Common Stock 2008-01-22 4 S 0 200 12.65 D 34418 D Common Stock 2008-01-22 4 S 0 182 12.66 D 34236 D Common Stock 2008-01-22 4 S 0 100 12.67 D 34136 D Common Stock 2008-01-22 4 S 0 118 12.6715 D 34018 D Common Stock 2008-01-22 4 S 0 200 12.69 D 33818 D Common Stock 2008-01-22 4 S 0 100 12.70 D 33718 D Common Stock 2008-01-22 4 S 0 200 12.705 D 33518 D Common Stock 2008-01-22 4 S 0 18 12.71 D 33500 D Common Stock 2008-01-22 4 S 0 200 12.72 D 33300 D Common Stock 2008-01-22 4 S 0 300 12.78 D 33000 D Common Stock 2008-01-22 4 S 0 118 12.8724 D 32882 D Sale was effected pursuant to a Rule 10b5-1 Trading Plan previously entered into by Reporting Person. Table 2 of 3 /s/ Marc Rubenstein, Attorney-in-fact 2008-01-24 -----END PRIVACY-ENHANCED MESSAGE-----